Structurally related mycotoxins ochratoxin A, ochratoxin B, and citrinin differ in their genotoxic activities and in their mode of action in human-derived liver (HepG2) cells: Implications for risk assessment

Nutrition and Cancer

Volumn 50, Issue 2, 2004, Pages 190-197

  Knasmüller, Siegfried ^a   Cavin, Christophe ^b   Chakraborty, Asima ^a   Darroudi, F ^c   Majer, Bernhard J ^a   Huber, Wolfgang W ^a   Ehrlich, Veronika A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CITRININ; OCHRATOXIN;

ANEUPLOIDY; ARTICLE; BACTERIUM CULTURE; CENTROMERE; CHROMOSOME BREAKAGE; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA PROBE; DOSE RESPONSE; DRUG STRUCTURE; GENOTOXICITY; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER HOMOGENATE; MICRONUCLEUS; MITOSIS INHIBITION; MUTAGEN TESTING; RISK ASSESSMENT;

CELL LINE, TUMOR; CITRININ; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIVER; MICRONUCLEUS TESTS; OCHRATOXINS; RISK ASSESSMENT;

BACTERIA (MICROORGANISMS); SALMONELLA;

EID: 12744273504     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5002_9     Document Type: Article

References (51)

1. Castegnaro M, Chernozemsky IN, Hietanen E, and Bartsch H: Are mycotoxins risk factors for endemic nephropathy and associated urothelial cancers? Arch Geschwulstforsch 60, 295-303, 1990.
2. Pitt JI: Toxigenic fungi and mycotoxins. Br Med Bull 56, 184-192, 2000.
3. IARC WHO: Mycotoxins, ARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Some Natural Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins. Lyon, France: IARC, 1993, pp 245-521.
4. Vukelic M, Sostaric B, and Belicza M: Pathomorphology of Balkan endemic nephropathy. Food Chem Toxicol 30, 193-200, 1992.
5. Ehrlich V, Darroudi F, Uhl M, Steinkellner H, Gann M, et al.: Genotoxic effects of ochratoxin A in human-derived hepatoma (HepG2) cells. Food Chem Toxicol 40, 1085-1090, 2002.
6. Castegnaro M, Mohr U, Pfohl-Leszkowicz A, Esteve J, Steinmann J, et al.: Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction. Int J Cancer 77, 70-75, 1998.
7. Lillehoj EB and Goransson B: Occurrence of ochratoxin- and citrinin-producing fungi on developing Danish barley grain. Acta Pathol Microbiol Scand B 88, 133-137, 1980.
8. Szebiotko K, Chelkowski J, Dopierala G, Godlewska B, and Radomyska W: Mycotoxins in cereal grain. I. Ochratoxin, citrinin, sterigmatocystin, penicillic acid and toxigenic fungi in cereal grain. Nahrung 25, 415-421, 1981.
9. Lepom P: Simultaneous determination of the mycotoxins citrinin and ochratoxin A in wheat and barley by high-performance liquid chromatography. J Chromatogr 355, 335-339, 1986.
10. World Health Organization: Environmental Health Criteria: Selected Mycotoxins: Ochratoxins, Trichothecenes, Ergot/[IPCS, International Programme on Chemical Safety]. Geneva: World Health Organization, 1990, pp 230-245.
11. Petkova-Bocharova T, Castegnaro M, Michelon J, and Maru V: Ochratoxin A and other mycotoxins in cereals from an area of Balkan endemic nephropathy and urinary tract tumours in Bulgaria. IARC Sci Publ 83-87, 1991.
12. Krogh P, Hald B, and Pedersen EJ: Occurrence of ochratoxin A and citrinin in cereals associated with mycotoxic porcine nephropathy. Acta Pathol Microbiol Scand B 81, 689-695, 1973.
13. IARC: Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours. Lyon, France: IARC Scientific Publications, 1991, pp 207-273.
14. Würgler FE, Friederich U, and Schlatter J: Lack of mutagenicity of ochratoxin A and B, citrinin, patulin and cnestine in Salmonella typhimurium TA102. Mutat Res 261, 209-216, 1991.
15. Wehner FC, Thiel PG, van Rensburg SJ, and Demasius IP: Mutagenicity to Salmonella typhimurium of some Aspergillus and Penicillium mycotoxins. Mutat Res 58, 193-203, 1978.
16. Krivobok S, Olivier P, Marzin DR, Seigle-Murandi F, and Steiman R: Study of the genotoxic potential of 17 mycotoxins with the SOS Chromotest. Mutagenesis 2, 433-439, 1987.
17. Sakai M, Abe K, Okumura H, Kawamura O, Sugiura Y, et al.: Genotoxicity of fungi evaluated by SOS microplate assay. Nat Toxins 1, 27-34, 1992.
18. Martin W, Lorkowski G, Creppy EE, Dirheimer G, and Roschenthaler R: Action of citrinin on bacterial chromosomal and plasmid DNA in vivo and in vitro. Appl Environ Microbiol 52, 1273-1279, 1986.
19. Liu BH, Yu FY, Wu TS, Li SY, Su MC, et al.: Evaluation of genotoxic risk and oxidative DNA damage in mammalian cells exposed to mycotoxins, patulin and citrinin. Toxicol Appl Pharmacol 191, 255-263, 2003.
20. Belitsky GA, Khovanova EM, Budunova IV, and Sharuptis HG: Mycotoxin induction of somatic mosaicism in Drosophila and DNA repair in mammalian liver cell cultures. Cell Biol Toxicol 1, 133-143, 1985.
21. Thust R and Kneist S: Activity of citrinin metabolized by rat and human microsome fractions in clastogenicity and SCE assays on Chinese hamster V79-E cells. Mutat Res 67, 321-330, 1979.
22. Pfeiffer E, Gross K, and Metzler M: Aneuploidogenic and clastogenic potential of the mycotoxins citrinin and patulin. Carcinogenesis 19, 1313-1318, 1998.
23. IARC WHO: Citrinin, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Some Naturally Occurring and Synthetic Food Components, Furocoumarins and Ultraviolet Radiation. Lyon, France: IARC, 1986, pp 67-82.
24. Knasmüller S, Parzefall W, Sanyal R, Ecker S, Schwab C, et al.: Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens. Mutat Res 402, 185-202, 1998.
25. Mersch-Sundermann V, Knasmüller S, Wu X, Darroudi F, and Kassie F: Use of a human derived liver cell line for the detection of cytoprotective, antigenotoxic and cogenotoxic agents. Toxicology in press 2004.
26. Uhl M, Helma C, and Knasmüller S: Evaluation of the single cell gel electrophoresis assay with human hepatoma (Hep G2) cells. Mutat Res 468, 213-225, 2000.
27. Natarajan AT and Darroudi F: Use of human hepatoma cells for in vitro metabolic activation of chemical mutagens/carcinogens. Mutagenesis 6, 399-403, 1991.
28. Ehrlich V, Darroudi F, Uhl M, Steinkellner H, Zsivkovits M, et al.: Fumonisin B(1) is genotoxic in human derived hepatoma (HepG2) cells. Mutagenesis 17, 257-260, 2002.
29. Darroudi F, Meijers CM, Hadjidekova V, and Natarajan AT: Detection of aneugenic and clastogenic potential of X-rays, directly and indirectly acting chemicals in human hepatoma (Hep G2) and peripheral blood lymphocytes, using the micronucleus assay and fluorescent in situ hybridization with a DNA centromeric probe. Mutagenesis 11, 425-433, 1996.
30. Duverger-van Bogaert M, Dierickx PJ, Stecca C, and Crutzen MC: Metabolic activation by a supernatant from human hepatoma cells: a possible alternative in mutagenic tests. Mutat Res 292, 199-204, 1993.
31. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254, 1976.
32. Pinkel D, Straume T, and Gray JW: Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 83, 2934-2938, 1986.
33. Uhl M, Helma C, and Knasmüller S: Single-cell gel electrophoresis assays with human-derived hepatoma (Hep G2) cells. Mutat Res 441, 215-224, 1999.
34. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, et al.: Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35, 206-221, 2000.
35. Helma C and Uhl M: A public domain image-analysis program for the single-cell gel-electrophoresis (comet) assay. Mutat Res 466, 9-15, 2000.
36. Lindl T and Bauer J: Zell-und Gewebekultur, Stuttgart, Germany: Gustav Fischer Verlag, 1994, pp 189-190.
37. Degen GH, Gerber MM, Obrecht-Pflumio S, and Dirheimer G: Induction of micronuclei with ochratoxin A in ovine seminal vesicle cell cultures. Arch Toxicol 71, 365-371, 1997.
38. Ehrlich V: Untersuchung der gentoxischen Effekte von nahrungsrelevanten Mykotoxinen in Humanzellen. Institute for Cancer Research and Tumorbiology, 2002.
39. Knasmüller S, Schwab CE, Land SJ, Wang CY, Sanyal R, et al.: Genotoxic effects of heterocyclic aromatic amines in human derived hepatoma (HepG2) cells. Mutagenesis 14, 533-540, 1999.
40. Oshimura M and Barrett JC: Chemically induced aneuploidy in mammalian cells: mechanisms and biological significance in cancer. Environ Mutagen 8, 129-159, 1986.
41. Gautier J, Richoz J, Welti DH, Markovic J, Gremaud E, et al.: Metabolism of ochratoxin A: absence of formation of genotoxic derivatives by human and rat enzymes. Chem Res Toxicol 14, 34-45, 2001.
42. Mally A, Zepnik H, Wanek P, Eder E, Dingley K, et al.: Ochratoxin A: lack of formation of covalent DNA adducts. Chem Res Toxicol 17, 234-242, 2004.
43. Schlatter C, Studer-Rohr J, and Rasonyi T: Carcinogenicity and kinetic aspects of ochratoxin A. Food Addit Contam 13, 43-44, 1996.
44. Gautier JC, Holzhaeuser D, Markovic J, Gremaud E, Schilter B, et al.: Oxidative damage and stress response from ochratoxin A exposure in rats. Free Radic Biol Med 30, 1089-1098, 2001.
45. Ruprich J and Ostry V: Health risk assessment of the mycotoxin ochratoxin A to humans: Czech Republic - Brno - 1991/92. Cent Eur J Public Health 1, 86-93, 1993.
46. Azemar B: Etude du role de l'ochratoxine A, une mycotoxine alimentaire, dans l'induction des cancers des voies urinaires chez l'Homme. Mécanismes moleculaires impliqués. Toulouse, France: Polytechnique of Toulouse, 2004.
47. Gekle M and Silbernagl S: The role of the proximal tabule in ochratoxin A nephrotoxicity in vivo: toxodynamic and toxokinetic aspects. Ren Physiol Biochem 17, 40-49, 1994.
48. Kirsch-Volders M, Vanhauwaert A, De Boeck M, and Decordier I: Importance of detecting numerical versus structural chromosome aberrations. Mutat Res 504, 137-148, 2002.
49. Duesberg P and Li R: Multistep carcinogenesis: a chain reaction of aneuploidizations. Cell Cycle 2, 202-210, 2003.
50. Elhajouji A, Van Hummelen P, and Kirsch-Volders M: Indications for a threshold of chemically-induced aneuploidy in vitro in human lymphocytes. Environ Mol Mutagen 26, 292-304, 1995.
51. Schuler M, Hasegawa L, Parks R, Metzler M, and Eastmond DA: Dose-response studies of the induction of hyperdiploidy and polyploidy by diethylstilbestrol and 17beta-estradiol in cultured human lymphocytes using multicolor fluorescence in situ hybridization. Environ Mol Mutagen 31, 263-273, 1998.